戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 opathy, seizures, autonomic instability, and hyperkinetic movements.
2 orphism, progressive psychomotor disability, hyperkinetic movements, and axial hypotonia with variabl
3            Early-onset torsion dystonia is a hyperkinetic movement disorder caused by a deletion of o
4 lonus dystonia syndrome is a childhood onset hyperkinetic movement disorder characterized by predomin
5  individuals from two families affected by a hyperkinetic movement disorder due to homozygous mutatio
6                         A common form of the hyperkinetic movement disorder dystonia is caused by mut
7                               The paroxysmal hyperkinetic movement disorder phenocopies a form of dys
8                                  Chorea is a hyperkinetic movement disorder resulting from dysfunctio
9 et torsion dystonia is an autosomal dominant hyperkinetic movement disorder that has recently been li
10 sion dystonia (ITD) is an autosomal dominant hyperkinetic movement disorder with incomplete penetranc
11 ormal, but developed ataxia and a paroxysmal hyperkinetic movement disorder.
12 ologically dystonia most closely resembles a hyperkinetic movement disorder.
13 spose some individuals to the development of hyperkinetic movement disorders and seizures.
14 at endogenous mu agonists may play a role in hyperkinetic movement disorders by inducing sustained ac
15   The dystonias are a heterogeneous group of hyperkinetic movement disorders characterised by involun
16 s are still lacking, effective management of hyperkinetic movement disorders demands that physicians
17 therapy for the treatment of hypokinetic and hyperkinetic movement disorders has, however, led to an
18                                              Hyperkinetic movement disorders include tremors, dystoni
19  manifest in parkinsonism or a wide range of hyperkinetic movement disorders including chorea, ballis
20 nt for medication-refractory hypokinetic and hyperkinetic movement disorders, and it is being explore
21  on studies in animal models and humans with hyperkinetic movement disorders, it is postulated that d
22  treat medically intractable hypokinetic and hyperkinetic movement disorders, the course of the palli
23 een shown to contribute to both epilepsy and hyperkinetic movement disorders.
24 lly targeted treatments for chorea and other hyperkinetic movement disorders.
25 ovel therapeutic target for the treatment of hyperkinetic movement disorders.
26 , has been extended to the treatment of many hyperkinetic movement disorders.
27 e receptor blocker, is used to treat several hyperkinetic movement disorders.
28 ed to reverse these changes in patients with hyperkinetic movement disorders.
29 n the subthalamic nucleus (STN) results in a hyperkinetic movement syndrome, similar to the HD phenot

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。